胃内バルーン市場分析：製品タイプ別・用途別 2034年

This report provides a comprehensive analysis of the gastric balloon market , focusing on market value, growth rate, and future forecast. It evaluates market trends from 2025 to 2034 and explains the factors supporting market expansion. It also analyzes regional trends and company participation, helping stakeholders understand the future direction and growth potential of the market.

Market size and forecast

The gastric balloon market is expected to be valued at USD 1.93 billion in 2025 and grow to USD 2.18 billion by 2026. The market is expected to reach USD 5.95 billion by 2034, registering a compound annual growth rate (CAGR) of 13.34% during the forecast period. This growth is driven by rising obesity rates, increasing demand for non-surgical weight loss options, and growing awareness of minimally invasive treatments.

This report provides insights into market growth trends, long-term outlook, and overall industry developments. It examines regional performance and competitive positioning, and provides clear market forecasts and projections to support strategic planning.

Market Segmentation

The market is segmented by product type, application, end-user, patient population, and distribution channel. This segmentation helps in understanding how gastric balloon solutions are designed, applied, and offered. It also provides a structural overview of the market utilization and industry organization.

By Product Type

This segment focuses on various gastric balloon designs used in weight management.

• Saline-filled gastric balloons: Filled with saline to create a feeling of fullness and support weight loss control.
  • Flavored gastric balloons: Use a flavored solution to enhance patient comfort.
  • Non-surgical gastric balloons: Used without surgery, offering a minimally invasive treatment option.
  • Adjustable gastric balloons: The balloon volume can be adjusted during treatment for better results.

By Application

This section discusses the medical and health applications of intragastric balloons.

• Weight Loss: Use in structured programs to support gradual weight loss.
  • Weight Loss Before Bariatric Surgery: Helps patients lose weight before surgery.
  • Gastroesophageal Reflux Management: Use for symptom management in select cases.
  • Other Gastrointestinal Disorders: Includes additional digestive health applications.

By end user

This segment focuses on healthcare settings where gastric balloon procedures are performed.

• Hospitals: Provide supervised treatment and follow-up care.
  Specialty Clinics: Focus on targeted weight management services.
  Ambulatory Surgery Centers: Offer outpatient treatment options. Weight Loss Centers:
  Offer non-surgical weight management programs.

By patient demographics

This segment focuses on patient groups based on age and gender.

• Adults (18-65 years): Primary users seeking weight management solutions.
  • Adolescents (under 18 years): Limited use under medical supervision.
  • Elderly (65 years and older): Use after careful health assessment.
  • Gender-specific male: Treatment tailored to male patients.
  • Gender-specific female: Treatment designed to meet the needs of female patients.

By distribution channel

This segment explains how the product reaches healthcare providers and patients.

• Direct sales: Manufacturers supply products directly to healthcare facilities.
  • Online retail: Enables digital purchasing and product access.
  • Distributors: Act as local sales and service partners.
  • Distributors and wholesalers: Manage large-scale product distribution.

Key Players

The market is competitive, and companies are focused on product innovation and expanding the availability of treatments.

• Apollo Endosurgery Inc.: Develops minimally invasive weight loss solutions.
  • Obalon Therapeutics Inc.: Focuses on swallowable gastric balloon systems.
  • Allurion Technologies Inc.: Specializes in non-surgical gastric balloon therapy.
  • Spatz FGIA: Offers adjustable gastric balloon technology.
  • ReShape Medical Inc.: Offers integrative weight loss solutions.

Companies are focused on innovation, product improvement, and expanding clinical adoption.

Regional Insights

The market is showing steady growth across major regions of the world.

• North America: Driven by high obesity rates and a strong healthcare infrastructure.
  • Europe: Supported by growing awareness of non-surgical weight loss options.
  • Asia Pacific: Growth driven by rising obesity rates and improved healthcare access.
  • Latin America: Moderate growth driven by increased focus on weight management.
  • Middle East and Africa: Steady development as healthcare services expand.

Source: https://www.valuemarketresearch.com/report/GastricBalloonMarket